1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow UV1: new trials by email Literature Review of UV1 trials Research Report on UV1
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tolerability and Efficacy of UV1 Vaccine in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Planned for First-line Treatment With Pembrolizumab UV1, Sargramostim for Injection, Pembrolizumab injection - Head and Neck Squamous Cell Carcinoma | Phase 2 | Unknown | Martin-Luther-Universität Halle-Wittenberg | 75 | 2021-08-02 | 2022-03-09 |
Squamous Cell Carcinoma of Head and Neck (1)
Martin-Luther-Universität Halle-Wittenberg (1)
Germany (1)